Is Editas Medicine Inc (NASDAQ:EDIT) A Better Buy Than Others After A -69.39% Fall In This Year?
In recent trading session, Editas Medicine Inc (NASDAQ:EDIT) saw 7.94 million shares changing hands at last check today with its beta currently measuring 2.00. Company’s